๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

JAK2V617F mutation in patients with thrombosis: to screen or not to screen?

โœ Scribed by S. G. XAVIER; T. GADELHA; S. M. REZENDE; I. R. ZALCBERG; N. SPECTOR

Book ID
111415267
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
98 KB
Volume
33
Category
Article
ISSN
1751-5521

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Screening of JAK2 V617F mutation in mult
Screening of JAK2 V617F mutation in multiple myeloma
โœ Fiorini, A; Farina, G; Reddiconto, G; Palladino, M; Rossi, E; Za, T; Laurenti, L ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 67 KB
High prevalence of the JAK2 V617F mutati
High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis
โœ Valerio De Stefano; Alessia Fiorini; Elena Rossi; Tommaso Za; Patrizia Chiusolo; ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 56 KB

We read with interest the special article byShneider et al. 1 , which was published in November 2006, but related to a conference held in March 2006. As regards hepatitis B, Shneider et al. state: "Unfortunately at present there are inadequate numbers of patients with sufficiently long follow-up to

Breast cancer in Canada: To screen or no
Breast cancer in Canada: To screen or not to screen?
โœ D. Wayne Taylor; Elizabeth Little ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 860 KB

Lomas (1988) and Sabatier (1987) have suggested models by which to examine the roles that values, scientific knowledge, institutions, and the learning process play in the formulation of both national and clinical health-care policies. Utilizing their frameworks, this article offers an explanation fo